Dr. Michelle P. Hudspeth
Claim this profileMedical University of South Carolina
Studies Acute Lymphoblastic Leukemia
Studies Acute Myelogenous Leukemia
11 reported clinical trials
19 drugs studied
Area of expertise
1Acute Lymphoblastic Leukemia
HLA-A negative
HLA-A positive
HLA positive
2Acute Myelogenous Leukemia
HLA-A negative
HLA-A positive
HLA positive
Affiliated Hospitals
Clinical Trials Michelle P. Hudspeth is currently running
Tabelecleucel
for Post-Transplant Cancer
The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) after failure of rituximab (SOT-R) and rituximab plus chemotherapy (SOT-R+C) or (2) allogeneic hematopoietic cell transplant (HCT) after failure of rituximab.
Recruiting2 awards Phase 312 criteria
Tabelecleucel
for EBV Associated Diseases
This trial tests tabelecleucel, a treatment using special immune cells, in patients with certain diseases related to the Epstein-Barr virus (EBV) who can't use or don't respond to standard treatments. It works by enhancing the immune system's ability to attack virus-infected cells. Tabelecleucel is being tested for recurring or hard-to-treat EBV-related diseases.
Recruiting1 award Phase 22 criteria
More about Michelle P. Hudspeth
Clinical Trial Related4 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Michelle P. Hudspeth has experience with
- Tabelecleucel
- Donor Search Prognosis Score
- N/A
- Tisagenlecleucel
- Fludarabine
- Cyclophosphamide
Breakdown of trials Michelle P. Hudspeth has run
Acute Lymphoblastic Leukemia
Acute Myelogenous Leukemia
Lymphoproliferative Disorder
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michelle P. Hudspeth specialize in?
Michelle P. Hudspeth focuses on Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia. In particular, much of their work with Acute Lymphoblastic Leukemia has involved HLA-A negative patients, or patients who are HLA-A positive.
Is Michelle P. Hudspeth currently recruiting for clinical trials?
Yes, Michelle P. Hudspeth is currently recruiting for 3 clinical trials in Charleston South Carolina. If you're interested in participating, you should apply.
Are there any treatments that Michelle P. Hudspeth has studied deeply?
Yes, Michelle P. Hudspeth has studied treatments such as Tabelecleucel, Donor Search Prognosis Score, N/A.
What is the best way to schedule an appointment with Michelle P. Hudspeth?
Apply for one of the trials that Michelle P. Hudspeth is conducting.
What is the office address of Michelle P. Hudspeth?
The office of Michelle P. Hudspeth is located at: Medical University of South Carolina, Charleston, South Carolina 29425 United States. This is the address for their practice at the Medical University of South Carolina.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.